Top Institutions in Ophthalmology - Retinal Diseases
Leading academic medical centers with strong ophthalmology and retinal disease research programs typically conduct early-phase clinical trials and translational research on novel neuroprotective agents like Fas inhibitors. Institutions with dedicated retinal research centers and experience in AMD clinical trials are best positioned to lead such investigations.
-
#1
Duke University Eye Center
Durham, NC
Duke University Eye Center is a leader in retinal disease research and clinical trials, with expertise in novel therapeutics for geographic atrophy and AMD. Their involvement in the ONL1204 phase 1b study highlights their pioneering role in Fas inhibition neuroprotection.
-
#2
Massachusetts Eye and Ear Infirmary (Harvard Medical School)
Boston, MA
Massachusetts Eye and Ear is renowned for its cutting-edge research in retinal degenerations and AMD, with extensive experience in neuroprotection and clinical trials of novel agents targeting retinal cell death pathways.
-
#3
Bascom Palmer Eye Institute (University of Miami)
Miami, FL
Bascom Palmer Eye Institute is a top-ranked ophthalmology center with a robust retinal research program, specializing in AMD and geographic atrophy clinical trials and novel therapeutic development including neuroprotective strategies.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a strong focus on retinal diseases and neuroprotection, with active research in apoptosis pathways and clinical trials targeting AMD and GA progression.
-
#5
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a comprehensive retinal research program with expertise in AMD and geographic atrophy, conducting early-phase clinical trials and translational studies on novel neuroprotective agents.